Harvard Radiation Oncology Program, Boston, MA.
Departments of Radiation Oncology and Neurological Surgery, University Hospitals Seidman Cancer Center Case Western Reserve University School of Medicine, Cleveland, OH.
JCO Oncol Pract. 2024 Jun;20(6):771-777. doi: 10.1200/OP.23.00674. Epub 2024 Feb 20.
With the expansion of proton radiation therapy centers across the United States and a gradually expanding body of academic evidence supporting its use, more patients are receiving-and asking about-proton therapy than ever before. Here, we outline, for nonradiation oncologists, the theoretical benefits of proton therapy, the clinical evidence to date, the controversies affecting utilization, and the numerous randomized trials currently in progress. We also discuss the challenges of researching and delivering proton therapy, including the cost of constructing and maintaining centers, barriers with insurance approval, clinical situations in which proton therapy may be approached with caution, and the issue of equitable access for all patients. The purpose of this review is to assist practicing oncologists in understanding the evolving role of proton therapy and to help nonradiation oncologists guide patients regarding this technology.
随着美国质子放射治疗中心的扩张,以及越来越多的学术证据支持其应用,接受质子治疗的患者比以往任何时候都多,他们也越来越关注质子治疗。在这里,我们为非放射肿瘤学家概述了质子治疗的理论优势、迄今为止的临床证据、影响应用的争议,以及目前正在进行的大量随机试验。我们还讨论了研究和提供质子治疗的挑战,包括建设和维护中心的成本、保险审批的障碍、质子治疗可能需要谨慎处理的临床情况,以及所有患者公平获得治疗的问题。本综述的目的是帮助肿瘤临床医生了解质子治疗的作用不断演变,并帮助非放射肿瘤医生指导患者了解这项技术。